snowdeal.org > {bio,medical}informatics

{bio,medical} informatics

Monday, July 16, 2001

bookmark: connotea :: del.icio.us ::digg ::furl ::reddit ::yahoo::

New Jersey Online Despite hoopla, genetic information firms far from profitability

"A year after the deciphering of the human genome boggled the world, investors are realizing that manipulating genes to fight disease is still in its infancy -- and far from profitable."

Nowhere is that more clear than in the industry for genetic information, or bioinformatics."

redux [06.01.01]
GenomeWeb Software Vendors Hungry for a Piece of the Burgeoning Bioinformatics Consulting Market
"Justin Saeks, an analyst with Frost & Sullivan, sees plenty of room for new players in the consulting market. "I think there is definitely a demand for this," said Saeks, "Maybe equal to or more than the software sales, depending on whether you include hardware with IT consulting."

A Frost & Sullivan study conducted for IBM predicted that life sciences companies would spend nearly $6.5 billion on IT services by 2004.

One reason for the surge of interest in the field is the maturation of data-generating technology, which has left biotech and pharma clients "struggling with the rate of change and the degree of integration on their shoulders," said Bob White, vice president of Accelrys' worldwide sales and consulting division."
redux [04.01.01]
BusinessWeek Bioinformatics
"The reason for this sudden feeding frenzy? Sales growth. Although analysts estimate that bioinformatics will grow into a $2 billion dollar industry in the next five years, most IT companies believe the payoffs will be much higher. An internal study commissioned by IBM, for instance, predicts that when the markets for high-performance computing, storage, and e-commerce combine with that of data management, the worldwide market for IT products and services in the life-sciences sector will swell to $43 billion by 2004. Looking at these kinds of numbers, "now is not the time to think small,'' says Caroline A. Kovac, vice-president of IBM's Global Life Sciences Business Unit."
redux [06.26.00]
Oscar Gruss & Son Trends in Commercial Bioinformatics
"The purpose of this document is to provide an overview of the rapidly emerging field of "commercial bioinformatics."

"For the purposes of this review, we define bioinformatics as the backbone computational tools and databases that support genomic and related research, which broadly encompasses the study of DNA structure/function, gene expression and protein production/structure/function."

[ rhetoric ]

“Bioinformatics will be at the core of biology in the 21st century. In fields ranging from structural biology to genomics to biomedical imaging, ready access to data and analytical tools are fundamentally changing the way investigators in the life sciences conduct research and approach problems. Complex, computationally intensive biological problems are now being addressed and promise to significantly advance our understanding of biology and medicine. No biological discipline will be unaffected by these technological breakthroughs.”

BIOINFORMATICS IN THE 21st CENTURY

[ search ]

[ outbound ]

{bio,medical} informatics

[ rhetoric ]

[ search ]

[ outbound ]

[ schwag ]

[ et cetera ]